These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35240984)

  • 1. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
    Viscido A; Valvano M; Stefanelli G; Capannolo A; Castellini C; Onori E; Ciccone A; Vernia F; Latella G
    BMC Gastroenterol; 2022 Mar; 22(1):92. PubMed ID: 35240984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
    Fukuda T; Naganuma M; Sugimoto S; Ono K; Nanki K; Mizuno S; Kimura K; Mutaguchi M; Nakazato Y; Takabayashi K; Inoue N; Ogata H; Iwao Y; Kanai T
    Inflamm Bowel Dis; 2019 Mar; 25(4):782-788. PubMed ID: 30265308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis.
    Lenfant M; Verstockt B; Sabino J; Vermeire S; Ferrante M
    Aliment Pharmacol Ther; 2024 Jan; 59(1):64-70. PubMed ID: 37843544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy.
    Di Ruscio M; Variola A; Vernia F; Lunardi G; Castelli P; Bocus P; Geccherle A
    Digestion; 2021; 102(4):534-545. PubMed ID: 32739919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of linked color imaging for the endoscopic diagnosis of mucosal healing in quiescent ulcerative colitis.
    Takagi T; Uchiyama K; Kajiwara-Kubota M; Kashiwagi S; Toyokawa Y; Hotta Y; Tanaka M; Inoue K; Dohi O; Yoshida N; Kamada K; Ishikawa T; Konishi H; Kishimoto M; Yagi N; Naito Y; Itoh Y
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2448-2454. PubMed ID: 33710655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Shah SC; Colombel JF; Sands BE; Narula N
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1245-1255.e8. PubMed ID: 26829025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Shimodaira Y; Watanabe K; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Scand J Gastroenterol; 2022 Feb; 57(2):165-168. PubMed ID: 34663142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
    Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
    Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
    Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study.
    Verstockt B; Pouillon L; Ballaux F; Jorissen C; Hoefkens E; Lembrechts N; Bossuyt P
    J Crohns Colitis; 2023 Jul; 17(7):1046-1054. PubMed ID: 36708189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.